140 related articles for article (PubMed ID: 9357524)
1. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.
Dhar A; Liu S; Klucik J; Berlin KD; Madler MM; Lu S; Ivey RT; Zacheis D; Brown CW; Nelson EC; Birckbichler PJ; Benbrook DM
J Med Chem; 1999 Sep; 42(18):3602-14. PubMed ID: 10479291
[TBL] [Abstract][Full Text] [Related]
3. Novel heteroarotinoids: synthesis and biological activity.
Spruce LW; Gale JB; Berlin KD; Verma AK; Breitman TR; Ji XH; van der Helm D
J Med Chem; 1991 Jan; 34(1):430-9. PubMed ID: 1992144
[TBL] [Abstract][Full Text] [Related]
4. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
[TBL] [Abstract][Full Text] [Related]
5. Heteroarotinoids. Synthesis, characterization, and biological activity in terms of an assessment of these systems to inhibit the induction of ornithine decarboxylase activity and to induce terminal differentiation of HL-60 cells.
Spruce LW; Rajadhyaksha SN; Berlin KD; Gale JB; Miranda ET; Ford WT; Blossey EC; Verma AK; Hossain MB; van der Helm D
J Med Chem; 1987 Aug; 30(8):1474-82. PubMed ID: 3612691
[TBL] [Abstract][Full Text] [Related]
6. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cells.
Liu S; Brown CW; Berlin KD; Dhar A; Guruswamy S; Brown D; Gardner GJ; Birrer MJ; Benbrook DM
J Med Chem; 2004 Feb; 47(4):999-1007. PubMed ID: 14761202
[TBL] [Abstract][Full Text] [Related]
8. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
9. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells.
Strickland S; Breitman TR; Frickel F; Nürrenbach A; Hädicke E; Sporn MB
Cancer Res; 1983 Nov; 43(11):5268-72. PubMed ID: 6577946
[TBL] [Abstract][Full Text] [Related]
11. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 2002 Feb; 178(3):186-94. PubMed ID: 11858735
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation.
Lotan R; Dawson MI; Zou CC; Jong L; Lotan D; Zou CP
Cancer Res; 1995 Jan; 55(2):232-6. PubMed ID: 7812950
[TBL] [Abstract][Full Text] [Related]
13. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
14. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
16. Specific antagonist of retinoid toxicity in mice.
Standeven AM; Johnson AT; Escobar M; Chandraratna RA
Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
[TBL] [Abstract][Full Text] [Related]
17. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
Flanagan JL; Willhite CC; Ferm VH
J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic effects of a new arotinoid, Ro 40-8757, and all-trans- and 13-cis-retinoic acids on rat breast cancer.
Teelmann K; Tsukaguchi T; Klaus M; Eliason JF
Cancer Res; 1993 May; 53(10 Suppl):2319-25. PubMed ID: 8485719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
